3rd Edition of the Cancer R&D World Conference (CRDWC 2027)

3rd Edition of the Cancer R&D World Conference (CRDWC 2027)

Welcome to the 3rd Edition of the Cancer R&D World Conference (CRDWC 2027), to be held in September 22-24, 2027, in Boston, MA, USA.

Theme: From Biomarker to Bedside: Accelerating the Next Generation of Cancer Therapies.

This conference promises to be a landmark event, showcasing the latest advancements, cutting-edge research, and transformative therapies in cancer research and development. Renowned global speakers will share their insights, present groundbreaking findings, and discuss innovative approaches to addressing the challenges of cancer care.

Attendees will engage in stimulating discussions, exchange ideas, and forge collaborations to shape the future of cancer research and patient care. From revolutionary therapies to pioneering diagnostic tools, this conference will provide a comprehensive overview of the evolving landscape of cancer care and the potential for future breakthroughs.

Join us in Boston as we embark on a journey of discovery, innovation, and collaboration in the fight against cancer. Mark your calendars and be part of this transformative experience!

Scientific Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy

Important Dates
Date formats: d/m/y
Event Details
Leave a Comment

Event Details